Caris Healthcare Medicare Approved Location: 242 Heritage Park Drive Suite 101, Murfreesboro, Tennessee 37129 Phone: (615) 217-8720 |
News Archive
Similar to other surgical procedures, orthopaedic surgery continues to progress toward more minimally invasive surgical techniques, with shorter inpatient length of stays and new opportunities for some procedures to shift to the outpatient care setting.
Takeda Pharmaceutical Company Limited (Takeda) announced today that its wholly-owned subsidiary Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for the fixed-dose combination therapy alogliptin/metformin, which combines alogliptin with metformin in a single tablet.
The Gerontological Society of America - the nation's largest interdisciplinary organization devoted to the field of aging - has chosen Kyriakos S. "Kokos" Markides, PhD, of the University of Texas Medical Branch as the 2015 recipient of the Robert W. Kleemeier Award.
Soligenix, Inc. a late-stage biopharmaceutical company, today reported preliminary results from its Phase 2 "proof-of-concept" exploratory clinical trial of orBec for the prevention of acute Graft-versus-Host disease (GVHD) in patients undergoing myeloablative conditioning regimens with initiation of dosing prior to hematopoietic cell transplantation (HCT) and continuing through the post-transplantation period.
Patients with schizophrenia who fail to take their medicines as prescribed are over one-and-a-half times as likely to be rehospitalised and use in-patient services as patients who stick to their medication regimen. Non-adherence predicted an excess annual cost per patient of £5000 for total service use.
› Verified 9 days ago